With the Food and Drug Administration approval of Prolia at the beginning of June, new hope is available for postmenopausal women with osteoporosis (PMO) at high risk for fracture. “This is a ...
With the Food and Drug Administration approval of Prolia at the beginning of June, new hope is available for postmenopausal women with osteoporosis (PMO) at high risk for fracture. “This is a ...
windblown commented on Ann Butenas' post Prolia for Postmenopausal Osteoporosis - The Benefits and the Risks